Skip to main page content

Anthony Khawaja

Keynote Speaker
Participates in 7 items

Anthony Khawaja PhD FRCOphth


Anthony Khawaja is Associate Professor and Honorary Consultant Ophthalmic Surgeon at the UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK. He is currently a UK Research & Innovation Future Leaders Fellow. Anthony’s research training began with a Welcome Trust funded PhD program at the University of Cambridge, including a Berkeley Fellowship supported period at Harvard Medical School. Anthony’s research interests concern the genetic and environmental causes of glaucoma and his ultimate aim is to develop prediction models that can enable efficient population screening of glaucoma and more personalized care of glaucoma patients in the clinic.  Anthony chairs the UK Glaucoma Genetics Consortium and is also leading an international collaboration to identify new modifiable risk factors for glaucoma.  In his spare time, Anthony is passionate about music: he plays the piano, composes, and enjoys listening to a broad range of music.
 

Financial disclosure: Dr Khawaja has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Abbvie,
  2. Aerie,
  3. Google Health,
  4. Novartis,
  5. Reichert,
  6. Santen,
  7. Thea

Sessions in which Anthony Khawaja participates

viernes 10 junio, 2022

Zona horaria: (GMT-05:00) Eastern Time (US & Canada)
9:45
9:45 - 11:15 | 1 hour 30 minutos
Glaucoma

Learning Objectives:At the end of this session participants will be able to:Describe the current surgical options available in management of glaucoma in Canada – filtering surgery and angle based surgeryIntegrate the most recent evidence for each surgical option and apply them to their clinical decision makingAssess new development in genomics and how it can optimize our surgical managementCanMEDS Roles:  

11:00

sábado 11 junio, 2022

Zona horaria: (GMT-05:00) Eastern Time (US & Canada)
7:00
7:00 - 9:00 | 2 hours
Current Concepts

Learning ObjectivesAt the end of this session, participants will be able to:Review latest techniques in corneal transplantation and when certain techniques would be most appropriateReview management strategies to treat non-healing corneal woundsDefine the signs and symptoms of Limbal Stem Cell DeficiencyDescribe the treatment modalities currently in use to treat&n...

7:02 - 7:12 | 10 minutos
Current ConceptsGlaucoma
9:45
9:45 - 11:15 | 1 hour 30 minutos
Glaucoma

Learning Objectives:• Integrate new development in genomics to their clinical practice in order to optimize their care for patients • Better communicate the implication of genomics research in their treatment• Assess and apply new knowledge in visual field analysis in monitoring glaucoma disease progression• Describe the application of artificial intelligence in glaucoma genomicsCanMEDS Roles: Health Advocate, Communicator

10:45